Avion Wealth’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-67
Closed -$16K 829
2022
Q4
$16K Hold
67
0.01% 232
2022
Q3
$16K Hold
67
0.01% 234
2022
Q2
$17K Hold
67
0.01% 219
2022
Q1
$22K Hold
67
0.01% 175
2021
Q4
$24K Hold
67
0.01% 168
2021
Q3
$22K Hold
67
0.01% 175
2021
Q2
$21K Hold
67
0.01% 173
2021
Q1
$21K Hold
67
0.01% 167
2020
Q4
$22K Hold
67
0.01% 177
2020
Q3
$19K Hold
67
0.01% 145
2020
Q2
$16K Hold
67
0.01% 145
2020
Q1
$10K Buy
+67
New +$11.1K ﹤0.01% 159

Other funds holding ABMD

Avion Wealth's ABMD Position: Q1 2023 in Review

Avion Wealth sold out of Abiomed Inc (ABMD) in Q1 2023, closing a stake of 67 shares — an estimated $16K sold.

Avion Wealth first reported a position in ABMD in Q1 2020 and held it in 12 quarters. The position peaked at $24K in Q4 2021. 2 funds tracked by Wall St. Rank hold ABMD as of Q1 2023.

  • Avion Wealth reported no remaining Abiomed Inc position as of Q1 2023 after selling out during the quarter.
  • Avion Wealth sold 67 Abiomed Inc shares in Q1 2023, an estimated $16K.
  • Avion Wealth first reported a position in Abiomed Inc in Q1 2020 and held it in 12 quarters.
  • Avion Wealth's Abiomed Inc position peaked at $24K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2023.

Based on Avion Wealth's 13F filing for Q1 2023, filed 5 May 2023.